# Programmed Intermittent Epidural Bolus for Labor Analgesia During First Stage of Labor-3

> **NCT02887222** · NA · COMPLETED · sponsor: **Samuel Lunenfeld Research Institute, Mount Sinai Hospital** · enrollment: 40 (actual)

## Conditions studied

- Labor Pain

## Interventions

- **DRUG:** Bupivacaine

## Key facts

- **NCT ID:** NCT02887222
- **Lead sponsor:** Samuel Lunenfeld Research Institute, Mount Sinai Hospital
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2016-08
- **Primary completion:** 2017-01
- **Final completion:** 2017-01
- **Target enrollment:** 40 (ACTUAL)
- **Last updated:** 2017-05-25


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02887222

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02887222, "Programmed Intermittent Epidural Bolus for Labor Analgesia During First Stage of Labor-3". Retrieved via AI Analytics 2026-05-27 from https://api.ai-analytics.org/clinical/NCT02887222. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*